Rxcurve
HCPCS J9293 · per 5 MG

Mitoxantrone hydrochl / 5 mg

Products billed under this code include Mitoxantrone Hydrochloride.

Payment limit per 5 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J9293

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Mitoxantrone Hydrochloride Pfizer Inc 61703-0343-18 4 $77.672
Mitoxantrone Hydrochloride Pfizer Inc 61703-0343-65 5 $97.09
Mitoxantrone Hydrochloride Pfizer Inc 61703-0343-66 6 $116.508
Mitoxantrone Hydrochloride FreseniUS Kabi USA, LLC 63323-0132-10 4 $77.672
Mitoxantrone Hydrochloride FreseniUS Kabi USA, LLC 63323-0132-12 5 $97.09
Mitoxantrone Hydrochloride Meitheal Pharmaceuticals Inc. 71288-0178-10 4 $77.672
Mitoxantrone Hydrochloride Meitheal Pharmaceuticals Inc. 71288-0179-13 5 $97.09

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $19.418 −$10.284 5 MG Mitoxantrone hydrochl / 5 mg v1, posted September 17, 2026
3Q26 $29.702 −$8.912 5 MG Mitoxantrone hydrochl / 5 mg v1, posted September 15, 2026
2Q26 $38.614 +$7.737 5 MG Mitoxantrone hydrochl / 5 mg v1, posted September 15, 2026
1Q26 $30.877 +$7.00 5 MG Mitoxantrone hydrochl / 5 mg v1, posted September 15, 2026
4Q25 $23.877 −$5.723 5 MG Mitoxantrone hydrochl / 5 mg v1, posted September 8, 2026
3Q25 $29.60 +$1.907 5 MG Mitoxantrone hydrochl / 5 mg v1, posted March 10, 2026
2Q25 $27.693 −$33.126 5 MG Mitoxantrone hydrochl / 5 mg v1, posted March 10, 2026
1Q25 $60.819 +$6.168 5 MG Mitoxantrone hydrochl / 5 mg v1, posted December 19, 2025
4Q24 $54.651 −$0.457 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 11, 2025
3Q24 $55.108 +$12.439 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 11, 2025
2Q24 $42.669 −$0.909 5 MG Mitoxantrone hydrochl / 5 mg v1, posted March 11, 2025
1Q24 $43.578 +$2.185 5 MG Mitoxantrone hydrochl / 5 mg v1, posted December 19, 2024
4Q23 $41.393 +$12.333 5 MG Mitoxantrone hydrochl / 5 mg v1, posted October 10, 2024
3Q23 $29.06 −$20.267 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 5, 2024
2Q23 $49.327 −$5.557 5 MG Mitoxantrone hydrochl / 5 mg v1, posted February 23, 2024
1Q23 $54.884 +$1.546 5 MG Mitoxantrone hydrochl / 5 mg v1, posted December 6, 2023
4Q22 $53.338 +$17.552 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 22, 2023
3Q22 $35.786 +$1.866 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 9, 2023
2Q22 $33.92 +$4.518 5 MG Mitoxantrone hydrochl / 5 mg v1, posted December 14, 2022
1Q22 $29.402 +$3.117 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 8, 2022
4Q21 $26.285 −$2.902 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 2, 2022
3Q21 $29.187 −$1.663 5 MG Mitoxantrone hydrochl / 5 mg v1, posted June 2, 2022
2Q21 $30.85 +$6.71 5 MG Mitoxantrone hydrochl / 5 mg v1, posted March 1, 2022
1Q21 $24.14 – 5 MG Mitoxantrone hydrochl / 5 mg v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files